• $5.7M
    Market Cap
  • -64.53%
    1-Year Change
  • Medical Devices
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
N/A
N/A
217
N/A
N/A
N/A
Cost of Revenue
N/A
N/A
N/A
N/A
N/A
N/A
Gross Profit
0
-100.00%
217
N/A
0
N/A
Sales and Marketing Expense
255,160
+17.96%
216,318
+59.55%
135,576
N/A
Research and Development Expense
-231,593
+39.83%
-165,621
-62.05%
-436,398
N/A
Depreciation and Amortization Expense
N/A
N/A
1.0M
N/A
N/A
N/A
Total Operating Expenses
1.8M
+36.68%
1.3M
N/A
N/A
N/A
Operating Profit
-1.8M
+36.70%
-1.3M
-189.29%
1.5M
N/A
Interest Income
6,000
N/A
N/A
N/A
N/A
N/A
Interest Expense
-1,650
-97.09%
-56,794
+261.42%
-15,714
N/A
Interest Income and Expense and Net
4,350
+107.66%
-56,794
+261.42%
-15,714
N/A
Total Nonoperating Income and Expense
-461,753
-73.67%
-1.8M
+74.88%
-1.0M
N/A
Income before Taxes
-2.2M
-26.71%
-3.1M
+24.23%
-2.5M
N/A
Income Taxes
N/A
N/A
N/A
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-2.2M
-25.87%
-3.0M
+22.81%
-2.5M
N/A
Net Income from Continuing Operations Applicable to Common
-2.2M
-26.71%
-3.1M
+24.23%
-2.5M
N/A
Basic EPS and Net Income
-0.01
-50.00%
-0.02
N/A
N/A
N/A
Diluted EPS and Net Income
-0.01
-50.00%
-0.02
N/A
N/A
N/A
Basic Weighted Average Shares
161.8M
+2.03%
158.6M
-44.65%
286.6M
N/A
Diluted Weighted Average Shares
161.8M
+2.03%
158.6M
N/A
N/A
N/A
Balance Sheet
Cash and Cash Equivalents
0
-100.00%
6,741
-93.78%
108,335
N/A
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
0
-100.00%
6,741
-93.78%
108,335
N/A
Total Current Assets
238,361
+20.65%
197,556
+75.66%
112,468
N/A
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Assets
112,951
+88.25%
60,000
N/A
N/A
N/A
Total Assets
247,527
+25.29%
197,556
+75.66%
112,468
N/A
Income Taxes Payable
750,000
0.00%
750,000
N/A
N/A
N/A
Total Short-Term Debt
1.2M
+102.42%
578,708
-57.76%
1.4M
N/A
Total Current Liabilities
4.6M
+79.98%
2.6M
+63.64%
1.6M
N/A
Total Long-Term Debt
1.2M
-86.81%
9.2M
+483.58%
1.6M
N/A
Total Long-Term Liabilities
250,000
-56.80%
578,708
+478.71%
100,000
N/A
Total Liabilities
4.6M
+79.98%
2.6M
+63.64%
1.6M
N/A
Retained Earnings
-9.5M
+30.81%
-7.3M
+71.11%
-4.2M
N/A
Total Stockholders Equity
-4.4M
+84.52%
-2.4M
+62.71%
-1.5M
N/A
Total Shares Outstanding
162.6M
+1.28%
160.5M
+3.25%
155.5M
N/A
Cash Flow
Cash from Operating Activities
-644,842
-2.34%
-660,302
+1.92%
-647,860
N/A
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
-9,166
N/A
N/A
N/A
N/A
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
647,267
+15.85%
558,708
+132.80%
240,000
N/A
Financials Ratio
Gross Margin
N/A
N/A
N/A
N/A
N/A
N/A
Operating Margin
N/A
N/A
-598,243.78%
N/A
N/A
N/A
Return on Assets
-1,004.95%
-48.36%
-1,946.23%
N/A
N/A
N/A
Return on Equity
66.10%
-57.93%
157.14%
N/A
N/A
N/A
Revenue Growth
N/A
N/A
N/A
N/A
N/A
N/A
Current Ratio
0.05
-32.99%
0.08
N/A
N/A
N/A
Cash Ratio
0.00
-100.00%
0.003
N/A
N/A
N/A
Debt-to-Equity Ratio
-0.54
-86.76%
-4.10
N/A
N/A
N/A
Debt-to-Assets Ratio
9.61
-80.50%
49.31
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow